Cellectis SA (NASDAQ:CLLS)

18.24
Delayed Data
As of Jan 17
 -0.21 / -1.14%
Today’s Change
9.50
Today|||52-Week Range
20.84
+6.54%
Year-to-Date
These Gene-Editing Pioneers Are Making Bold Bets in Agriculture
Jan 18 / MotleyFool.com - Paid Partner Content
Why Iovance Biotherapeutics Shares Dropped 11.8% Today
Jan 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close18.45
Today’s open18.64
Day’s range18.09 - 18.67
Volume243,049
Average volume (3 months)125,411
Market cap$773.4M
Data as of 3:59pm ET, 01/17/2020

Growth & Valuation

Earnings growth (last year)+31.22%
Earnings growth (this year)-28.28%
Earnings growth (next 5 years)+1.50%
Revenue growth (last year)-49.92%
P/E ratioNM
Price/Sales53.38
Price/Book1.89

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp+0.04+0.23%
COLLCollegium Pharmaceut...-0.51-2.13%
GNFTGenfit SA-0.11-0.54%
PRVBProvention Bio Inc+0.66+4.08%
Data as of 4:00pm ET, 01/17/2020

Financials

Next reporting dateMarch 16, 2020
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$12.7M
Annual profit (last year)-$78.6M
Net profit margin-618.12%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Paris, Ile-de-france

Forecasts